ALTERED HLA EXPRESSION BY METASTATIC CERVICAL-CARCINOMA CELLS AS A FACTOR IN IMPAIRED IMMUNE SURVEILLANCE

被引:44
作者
HILDERS, CGJM
MUNOZ, IM
NOOYEN, Y
FLEUREN, GJ
机构
[1] Department of Pathology, University of Leiden
关键词
D O I
10.1006/gyno.1995.1156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The altered expression of histocompatibility leukocyte antigens (HLA) in the development to cervical carcinoma suggests that tumor progression may be related to impaired recognition by host immune defense mechanisms. To investigate whether this phenomenon plays a role in the process of metastasis of cervical cancer, we analyzed and compared the HLA expression with the number of infiltrating immune cells in primary cervical carcinoma and related autologous metastases (n = 30) by staining serial paraffin and corresponding frozen sections with a panel of monoclonal antibodies. In 60% of the cervical metastases, compared to 21% of the primary tumors, a downregulation of monomorphic HLA class I antigens was observed, with frequent allele-specific alterations. In 50% the HLA class II expression was slightly increased on the metastatic tumor cells in comparison to the primary tumor. In addition, variability of alterations in HLA expression was observed between different metastases in the same patient. A minor infiltration of immune cells was present in cervical metastases compared to the primary tumors, especially in the HLA class I-downregulated metastases. Furthermore, loss of HLA class I expression on the metastatic tumor cells resulted in a significant decrease of tumor-infiltrating CD8(+) T lymphocytes. These findings suggest that in cervical carcinoma loss of HLA class I expression plays a decisive role in the escape from immune surveillance leading to a greater metastatic potential of tumor cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:366 / 375
页数:10
相关论文
共 43 条
[1]  
ADAMS TE, 1983, IMMUNOLOGY, V50, P613
[2]   HETEROGENEITY IN SURFACE-ANTIGEN AND GLYCOPROTEIN EXPRESSION OF CELL-LINES DERIVED FROM DIFFERENT MELANOMA METASTASES OF THE SAME PATIENT - IMPLICATIONS FOR THE STUDY OF TUMOR-ANTIGENS [J].
ALBINO, AP ;
LLOYD, KO ;
HOUGHTON, AN ;
OETTGEN, HF ;
OLD, LJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (06) :1764-1778
[3]   DISTINCTIVE FUNCTIONAL-CHARACTERISTICS OF HUMAN LYMPHOCYTES-T DEFINED BY E-ROSETTING OR A MONOCLONAL ANTI-T-CELL ANTIBODY [J].
BEVERLEY, PCL ;
CALLARD, RE .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (04) :329-334
[4]  
BLAUSTEIN A, 1987, BLAUSTEINS PATHOLOGY, P186
[5]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545
[6]   LOSS OF MHC CLASS-I EXPRESSION IN CERVICAL CARCINOMAS [J].
CONNOR, ME ;
STERN, PL .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (06) :1029-1034
[7]  
CORDONCARDO C, 1991, CANCER RES, V51, P6372
[8]   THE MEMBRANE-ANTIGENS OF HUMAN COLORECTAL-CANCER CELLS - DEMONSTRATION WITH MONOCLONAL-ANTIBODIES OF HETEROGENEITY WITHIN AND BETWEEN TUMORS AND OF ANOMALOUS EXPRESSION OF HLA-DR [J].
DAAR, AS ;
FABRE, JW .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :209-&
[9]  
DEBAETSELIER P, 1980, NATURE, V288, P179
[10]   IMMUNOLOGICAL SURVEILLANCE OF TUMORS IN THE CONTEXT OF MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION OF T-CELL FUNCTION [J].
DOHERTY, PC ;
KNOWLES, BB ;
WETTSTEIN, PJ .
ADVANCES IN CANCER RESEARCH, 1984, 42 :1-65